Directors of the $12 billion California stem cell agency will meet at the end of this month to begin to tackle the sweeping, new tasks that voters have laid at their feet -- tasks that range from spending $1.5 billion on neurodegenerative diseases to creating affordable access to what are hoped to be nearly miraculous therapies for a host of terrible af…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.